| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 1, 2026 | ±4.8% | -3.4% | over-priced |
| October 24, 2025 | ±4.1% | -1.1% | over-priced |
| July 25, 2025 | ±4.6% | +0.5% | over-priced |
| April 25, 2025 | ±6.0% | -0.2% | over-priced |
| October 25, 2024 | ±2.6% | -0.6% | over-priced |
| April 26, 2024 | ±3.1% | +1.2% | over-priced |
| October 27, 2023 | ±1.8% | -1.1% | over-priced |
| July 28, 2023 | ±2.3% | -1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.72 | $7.6B | $943M |
| Q4 FY2025 | $0.93 | $6.4B | $1.2B |
| Q3 FY2025 | $0.97 | $6.2B | $1.3B |
| Q2 FY2025 | $0.86 | $5.7B | $1.1B |
Amphenol Corporation (APH) reports in 95 days, with the next report estimated for September 16, 2026. Across the last 8 reports, options priced an average ±3.7% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced APH's earnings risk. Fundamentals into the print: EPS up 24.1% year-over-year, revenue up 58.4%. QuantLogix's live 5-factor engine currently reads APH as a buy at 63/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →